Immix Biopharma (IMMX) Selling, General & Administrative (2021 - 2026)
Immix Biopharma (IMMX) recorded Selling, General & Administrative of $7.12 million in Q2 2026, up 159.5% from $2.75 million a year earlier and up 47.7% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Selling, General & Administrative (2021 - 2026) Analysis & Trends
On a TTM basis, Immix Biopharma's Selling, General & Administrative came in at $20.19 million as of Jun 30, 2026, up 68.0% year-over-year; for FY2025, it came in at $13.7 million, up 20.3% from FY2024.
- Annual Selling, General & Administrative has increased for five straight years, with a five-year compound annual growth rate of 131.6% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $11.38 million in FY2024 (+53.7%), $7.41 million in FY2023 (+84.1%), $4.02 million in FY2022 (+228.3%) and $1.23 million in FY2021 (+495.8%).
- The Q2 2026 figure is the highest quarterly Selling, General & Administrative in data going back to Q1 2021.
- On a year-over-year basis, Selling, General & Administrative has increased for 18 consecutive quarters, with growth averaging 49.0% over the last eight quarters.
- Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 4.4% (Q3 2025) to 428.4% (Q2 2022).
- Per Business Quant, the preceding three quarters came in at $4.82 million (Q1 2026), $5.17 million (Q4 2025) and $3.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Immix Biopharma | 731.81 Mn | 731.81 Mn | - | 7.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.12 Mn |
| Mar 31, 2026 | 4.82 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 2.75 Mn |
| Mar 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 3.61 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 2.48 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 837,441.00 |
| Jun 30, 2022 | 953,203.00 |
| Mar 31, 2022 | 700,507.00 |
| Dec 31, 2021 | 589,102.00 |
| Sep 30, 2021 | 318,301.00 |
API Access
Immix Biopharma Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();